Rajeeve, S., Derkach, A., Devlin, S., Santos, J., Przemielewska, A., Sood, T., Castro, F., Atkinson, T., Maclachlan, K., Hashmi, H., Tan, C., Korde, N., Hultcrantz, M., Lesokhin, A., Hassoun, H., Dahi, P., Scordo, M., Chung, D., Landau, H., Shah, G., Landgren, O., Giralt, S., Mailankody, S., Usmani, S., Shah, U. (2025). Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma – final results from a randomized investigator-initiated trial. Blood. https://doi.org/10.1182/blood-2025-2273